J Gen Intern Med 24(1):129131 Kamata Y, Takano K, Kishihara E, Watanabe M, Ichikawa R, Shichiri M (2017) Distinct clinical characteristics and therapeutic modalities for diabetic ketoacidosis in type 1 and type 2 diabetes mellitus
PLP is required for the formation of anthranilic acid, 3-hydroxyanthranilic acid, kynurenic acid, and xanthurenic acid
Ozempic Eyes: GLP-1 Drugs and Vision Loss Ozempic and other GLP-1s may increase your risk of a serious eye condition called non-arteritic anterior ischemic optic neuropathy (NAION)
However, medications work best when combined with healthy lifestyle habits
M.MalnicG.et al
On the basis of these results, two phase 2 randomized clinical trials were designed without food or water restrictions, wherein orforglipron treatment demonstrated robust glycemic control and body weight reduction in a 26-week study in participants with T2D and in a 36-week study in participants with obesity [26, 27]